SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-150305
Filing Date
2022-05-13
Accepted
2022-05-13 17:28:11
Documents
47
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d328420d10q.htm   iXBRL 10-Q 703499
2 EX-31.1 d328420dex311.htm EX-31.1 10427
3 EX-31.2 d328420dex312.htm EX-31.2 10574
4 EX-32.1 d328420dex321.htm EX-32.1 4385
5 EX-32.2 d328420dex322.htm EX-32.2 4393
  Complete submission text file 0001193125-22-150305.txt   3719092

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kvsa-20220331.xsd EX-101.SCH 33707
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kvsa-20220331_cal.xml EX-101.CAL 19502
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kvsa-20220331_def.xml EX-101.DEF 193645
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kvsa-20220331_lab.xml EX-101.LAB 239279
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kvsa-20220331_pre.xml EX-101.PRE 235970
41 EXTRACTED XBRL INSTANCE DOCUMENT d328420d10q_htm.xml XML 536911
Mailing Address 2128 SAND HILL ROAD MENLO PARK CA 94025
Business Address 2128 SAND HILL ROAD MENLO PARK CA 94025 650-376-8500
Khosla Ventures Acquisition Co. (Filer) CIK: 0001841873 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40131 | Film No.: 22924167
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences